Previous 10 |
home / stock / orinf / orinf news
ORION CORPORATION PRESS RELEASE 27 January 2023 at 14:00 EET Positive CHMP opinion for darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer CHMP recommendation is based on the data from the Phase III ARASENS trial, which d...
Orion Oyj ( OTCPK:ORINF ): 1H GAAP EPS of €0.88. Revenue of €553.4M (+5.7% Y/Y). Operating profit was EUR 153 million. Return on capital employed before taxes was 34%. Cash flow from operating activities per share was EUR 0.59. The out...
Orion Oyj (ORINF) Q2 2022 Results Conference Call July 15, 2022 6:30 AM ET Company Participants Tuukka Hirvonen - Head, IR Timo Lappalainen - CEO Jari Karlson - CFO Conference Call Participants Jo Walton - Credit Suisse Sami Sarkamies - Danske Ban...
The following slide deck was published by Orion Oyj in conjunction with their 2022 Q2 earnings call. For further details see: Orion Oyj 2022 Q2 - Results - Earnings Call Presentation
Orion Oyj (ORINF) Q1 2022 Results Conference Call April 28, 2022 06:30 AM ET Company Participants Tuukka Hirvonen - Head, IR Timo Lappalainen - CEO Jari Karlson - CFO Conference Call Participants Harry Sephton - Credit Suisse Sami Sarkamies - Danske Bank Presentation Tuukka Hirvonen Good afte...
Orion Oyj press release (OTCPK:ORINF): Q1 GAAP EPS of €0.41. Revenue of €270.6M (+0.7% Y/Y). Operating profit was €71M Profit before taxes was €72M Equity ratio was 53%. Return on capital employed before taxes was 36%. Return on equity after tax...
My portfolio crossed the mark where I could lock in capital gains, switch decidedly to income stocks and retire today. That is, if these income stocks yield at least some 4.5%. Yield is easy to find, but can it be relied on? For further details see: High Yield And Low Co...
AstraZeneca's innovative culture earned it a place as one of the leading biotechs globally. Revenue growth from COVID vaccine sales and some key markets provide strong tailwinds for the company's share in the second half of 2021. Most of AstraZeneca's revenue comes from a handful ...
News, Short Squeeze, Breakout and More Instantly...
Orion Corp New B Shs Company Name:
ORINF Stock Symbol:
OTCMKTS Market:
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 17 JULY 2024 at 8.30 EEST Inside information: Phase III ARANOTE trial of darolutamide in combination with androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer meets primary endpoint ...
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 1 JULY 2024 at 15:15 EEST Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metas...
ORION CORPORATION PRESS RELEASE 03 June 2024 at 09.30 EEST Orion is developing the Finnish life science industry in a unique collaboration project Orion is participating in a project led by the University of Turku for which Business Finland recently granted 11.7M€ funding. Th...